Dexamethasone in Myeloma Pathway Research
2026-08-09
Dexamethasone is more than a glucocorticoid anti-inflammatory reagent: it can serve as a mechanistic perturbation tool in genetically diverse myeloma cell-line panels. This guide connects DHAP assay design with mutation-aware interpretation and translational inflammation models.
Sulfamonomethoxine Toxicity Across Aquatic Species
2026-08-08
The reference study evaluates the acute and chronic toxicity of the veterinary sulfonamide antibiotic sulfamonomethoxine across aquatic organisms representing algae, cladocerans, and fish. Its comparative design shows that microalgae are more sensitive than cladocerans, supporting species-specific ecological risk assessment and more careful management of aquaculture antibiotic residues.
Streptavidin – Cy5: Reliable Biotin Detection
2026-08-07
This scenario-driven guide explains how Streptavidin – Cy5 (SKU K1080) supports biotin detection in viability, proliferation, cytotoxicity, imaging, and flow cytometry workflows. It connects practical reagent selection and control design with findings from a recent USP42 breast cancer study.
Nifedipine (BAY-a-1040): Advanced Insights into Calcium and
2026-08-07
Explore the multifaceted research applications of Nifedipine (BAY-a-1040), a potent L-type calcium channel blocker. This article reveals novel intersections between calcium influx inhibition, iron metabolism, and cytochrome P450 regulation, offering deeper mechanistic and practical guidance for high-impact assays.
PFHxS-Induced Hepatotoxicity in Larval Zebrafish via PPARα P
2026-08-06
This study demonstrates that perfluorohexanesulfonic acid (PFHxS), a prevalent short-chain PFAS, induces hepatotoxicity in larval zebrafish through the PPAR signaling pathway. The research integrates transcriptomic profiling, histopathology, and PPARα antagonism to mechanistically link PFHxS exposure with disrupted liver development and function, providing critical insights for aquatic toxicology and metabolic disease modeling.
Tunable Human Intestinal Organoids: Balancing Renewal and Di
2026-08-06
This study introduces a human intestinal organoid system that achieves a controlled balance between stem cell self-renewal and differentiation using small molecule pathway modulators. The approach enables scalable, high-diversity cultures without artificial spatial gradients, offering new opportunities for disease modeling and high-throughput screening.
THZ1: Covalent CDK7 Inhibitor Empowering Cancer Research
2026-08-05
THZ1, a highly selective covalent CDK7 inhibitor from APExBIO, is transforming transcriptional regulation studies and T-ALL cancer research with its unique mechanism and robust potency. This article dissects applied workflows, troubleshooting strategies, and the impact of resistance mutations, guiding researchers toward more effective experimental designs.
nor-NOHA Acetate: Precision Arginase Inhibition in Cancer Re
2026-08-05
nor-NOHA (acetate) empowers researchers to dissect arginine metabolism and modulate immune escape mechanisms in cancer models. This guide delivers actionable workflows, troubleshooting strategies, and translational insights, leveraging APExBIO’s high-purity inhibitor for reproducible and data-driven results.
(-)-Norepinephrine (+)-bitartrate in Renal Vascular Research
2026-08-04
Discover how (-)-Norepinephrine (+)-bitartrate advances renal vascular and adrenergic signaling research, offering nuanced insight into blood flow regulation and sepsis models. This article explores protocol optimization, mechanistic depth, and practical assay implications for innovative cardiovascular experimentation.
Protease Inhibitor Cocktail for Precision OXPHOS Protein Sta
2026-08-04
The Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) from APExBIO empowers researchers to achieve uncompromised protein integrity during cell and tissue extraction, crucial for mitochondrial and OXPHOS research. This guide translates cutting-edge anti-tumor workflows into actionable protocols, troubleshooting tips, and optimized use-cases for high-fidelity protein analysis.
6-FAM SE: Next-Generation Fluorescent Labeling for Molecular
2026-08-03
Explore how 6-FAM SE (6-Carboxyfluorescein N-hydroxysuccinimide ester) redefines durable, high-sensitivity labeling in gene sequencing and proteomics. This article uniquely connects its mechanistic advantages to evolving nanoparticle-based immunotherapies, offering actionable guidance beyond typical workflow articles.
MG-132: Advanced Strategies for Proteasome Inhibition Assays
2026-08-03
Explore the science behind MG-132 as a peptide aldehyde proteasome inhibitor for apoptosis and cell cycle research. This in-depth article reveals unique mechanistic insights and protocol strategies, distinguishing itself from standard guides.
Bystander Necroptosis in Lung Epithelium After Ricin Exposur
2026-08-02
Kempen et al. reveal how ricin toxin-induced apoptosis in immune cells triggers secondary necroptosis in lung epithelial cells via inflammatory bystander signaling. This study underscores the importance of cell death cross-talk and provides valuable insight into the mechanisms underlying ricin-induced lung injury.
GDC-0994: Advancing ERK1/2 Inhibition from Cancer to Liver M
2026-08-01
This thought-leadership article explores the pivotal role of GDC-0994—a selective ERK1/2 inhibitor—in bridging oncology and hepatic research. By dissecting the mechanistic rationale, reporting translational validation, and offering actionable protocols, it empowers translational researchers to leverage ERK pathway inhibition across both tumorigenesis and estrogen-induced cholestasis models. Drawing on recent breakthroughs in phytoestrogen-induced liver injury, it sets a new benchmark for cross-domain experimental design and workflow optimization.
p-Cresyl Sulfate Drives Aortic Valve Calcification via Kloth
2026-07-31
This article examines how the reference study reveals a mechanistic link between p-cresyl sulfate (PCS) and accelerated calcification of aortic valvular interstitial cells (VICs) in chronic kidney disease, mediated through disruption of klotho and sirtuin-1 signaling. The findings clarify the pathways underlying cardiovascular risk in CKD and highlight experimental parameters for modeling these processes.
458 records 9/31 page Previous Next First page 上5页 678910 下5页 Last page